News und Analysen
Vistagen CEO Shawn Singh to Join Executive Roundtable Discussing Mental Health at Concordia Annual Summit
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous
Vistagen Presents Poster at Psych Congress 2022 Highlighting Effect of PH94B on Nasal Electrogram Responses and Biomarkers of Autonomic Nervous System Activity in Healthy Human Subjects
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system
Vistagen to Participate in Upcoming Morgan Stanley and Baird Healthcare Conferences
Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety
Vistagen to Proceed with PALISADE-2 Phase 3 Clinical Trial of PH94B in Social Anxiety Disorder following Interim Analysis
Vistagen Therapeutics, Inc. (Nasdaq: VTGN) (Vistagen, the Company), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety
Beam Global Shines Brightly in the EV Infrastructure Space
Beam Global Inc. (NASDAQ: BEEM) is emerging as a standout in the electric vehicle (EV) infrastructure space. As the EV movement continues to spread as more EVs get on the road, EV charging
Beam Global Shines Brightly in the EV Infrastructure Space
Key Points
- Beam makes 100% sustainable EV charging and energy storage solutions.
- Its EV ARC charging system is solar-powered and requires no construction and no electricity or connection to
Heat Biologics Aktie: Das sieht gar nicht gut aus
Palatin-Aktie: Hier kann jetzt alles passieren
Heat Biologics, tut es schon wieder!
Palatin Aktie: Jetzt verkaufen?
Heat Biologics-Aktie: Keine Sorge!
Palatin Aktie: Das haben nur Profis kommen sehen …